Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 1998;82:63-81

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nygren, A.
Right arrow Articles by Giles, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nygren, A.
Right arrow Articles by Giles, W. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*POTASSIUM
(Circulation Research. 1998;82:63-81.)
© 1998 American Heart Association, Inc.


Original Contributions

Mathematical Model of an Adult Human Atrial Cell

The Role of K+ Currents in Repolarization

A. Nygren, C. Fiset, L. Firek, J. W. Clark, D. S. Lindblad, R. B. Clark, , W. R. Giles

From the Department of Electrical and Computer Engineering (A.N., J.W.C., D.S.L.), Rice University, Houston, Tex, and the Department of Physiology and Biophysics (C.F., L.F., R.B.C., W.R.G.), University of Calgary (Canada) Medical School.

Correspondence to Dr J.W. Clark, Department of Electrical and Computer Engineering, Rice University, 6100 South Main, Houston, TX 77005-1892. E-mail jwc{at}rice.edu


*    Abstract
up arrowTop
*Abstract
down arrowIntroduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowAppendix 1
down arrowAppendix 2
down arrowReferences
 
Abstract—We have developed a mathematical model of the human atrial myocyte based on averaged voltage-clamp data recorded from isolated single myocytes. Our model consists of a Hodgkin-Huxley–type equivalent circuit for the sarcolemma, coupled with a fluid compartment model, which accounts for changes in ionic concentrations in the cytoplasm as well as in the sarcoplasmic reticulum. This formulation can reconstruct action potential data that are representative of recordings from a majority of human atrial cells in our laboratory and therefore provides a biophysically based account of the underlying ionic currents. This work is based in part on a previous model of the rabbit atrial myocyte published by our group and was motivated by differences in some of the repolarizing currents between human and rabbit atrium. We have therefore given particular attention to the sustained outward K+ current (Isus), which putatively has a prominent role in determining the duration of the human atrial action potential. Our results demonstrate that the action potential shape during the peak and plateau phases is determined primarily by transient outward K+ current, Isus, and L-type Ca2+ current (ICa,L) and that the role of Isus in the human atrial action potential can be modulated by the baseline sizes of ICa,L, Isus, and the rapid delayed rectifier K+ current. As a result, our simulations suggest that the functional role of Isus can depend on the physiological/disease state of the cell.


Key Words: human atrium • repolarization • sustained outward current • computer modeling • cardiac action potential


*    Introduction
up arrowTop
up arrowAbstract
*Introduction
down arrowMaterials and Methods
down arrowResults
down arrowDiscussion
down arrowAppendix 1
down arrowAppendix 2
down arrowReferences
 
Within the past 5 years, quite extensive voltage-clamp and action potential data from human atrial myocytes have been published from a number of laboratories. In most cases the human atrial tissue was obtained during open heart surgery, in which small pieces of the right atrial appendage are excised as part of the cannulation procedure for cardiopulmonary bypass. However, cardiac tissue can also be obtained from the free wall of the atrium during valve replacement procedures, from explanted failing hearts during heart transplantations, or from donor hearts that cannot be used for transplantation. Once a specimen of cardiac tissue is obtained, enzymatic dispersion techniques are used to isolate single cardiac cells, from which action potential and voltage-clamp data can be recorded. We have made recordings of the outward K+ currents, which are responsible for repolarization in human atrial myocytes.1 2 On the basis of these data, as well as other published results, we have developed the first comprehensive mathematical model of the electrophysiological responses of a representative human atrial cell.

There are a number of published mathematical models that simulate the electrophysiological responses in several different species and cardiac cell types. Examples include the Purkinje fiber model of DiFrancesco and Noble,3 the Hilgemann and Noble atrial model,4 the Earm and Noble model of the single atrial cell,5 the bullfrog atrial and sinus venosus models of Rasmusson and colleagues,6 7 the ventricular cell models of Luo and Rudy,8 9 10 11 the rabbit sinoatrial node cell model of Demir et al,12 and the rabbit atrial cell model of Lindblad et al.13 Recently, the emphasis has shifted from general models, based on voltage-clamp data from several species,3 4 to more detailed models based on data from single isolated cells from a particular species. This is a direct reflection of the progress made in experimental work and the resulting availability of more comprehensive data. Our goal was to develop a model that is sufficiently accurate to have predictive capabilities for selected aspects of the electrophysiological responses in human atrium. Emphasis has been placed on the functional roles of the K+ currents during repolarization.


*    Materials and Methods
up arrowTop
up arrowAbstract
up arrowIntroduction
*Materials and Methods
down arrowResults
down arrowDiscussion
down arrowAppendix 1
down arrowAppendix 2
down arrowReferences
 
Basic Assumptions
Our model is of the general type first introduced by DiFrancesco and Noble3 and is based, in part, on the rabbit atrial model of Lindblad, Murphey, Clark, and Giles13 (hereafter referred to as the LMCG model). As shown in Fig 1Down, the model consists of a Hodgkin-Huxley–type electrical equivalent circuit for the sarcolemma coupled with a fluid compartment model. The dimensions of the human atrial myocyte are assumed identical to those of the rabbit atrial cell in the LMCG model. These dimensions (cylindrical geometry of 130-µm length and 11-µm diameter) are very close to the dimensions of human atrial myocytes (eg, 120-µm length and 10- to 15-µm diameter14 ). In addition, we have used a total cell capacitance of 50 pF,which agrees very well with our experimental observations for human atrial myocytes (51.9±3.5 pF, n=52).



View larger version (40K):
[in this window]
[in a new window]
 
Figure 1. Schematic representation of the mathematical model of the human atrial cell. A, Electrical equivalent circuit for the sarcolemma. B, Fluid compartment model, including intracellular, cleft, and extracellular spaces.

Membrane Currents
Fig 1AUp shows the electrical equivalent circuit for the sarcolemma of the human atrial cell. It includes each of the ionic currents that are known to contribute to the action potential in human atrial myocytes (INa, ICa,L, It, Isus, IK,r, IK,s, and IK1), the Ca2+ and Na+-K+ pump and Na+-Ca2+ exchanger currents responsible for maintaining intracellular ion concentrations (ICaP, INaK, and INaCa), and the Na+ and Ca2+ background (leakage) currents (IB,Na and IB,Ca). Mathematical expressions describing the time and voltage dependence of the ionic currents have been developed on the basis of published voltage-clamp data recorded predominantly from human atrial myocytes. (See "Glossary" after Appendix 2Down for terms used in text, figures, and tables.)

Na+ Current: INa
Voltage-clamp data for INa in human atrial and ventricular myocytes, recorded at 17°C have been published by Sakakibara and colleagues.15 16 These data suggest that the activation threshold is very close to the resting potential ({approx}-75 mV), which seems unrealistic, given that atrial and ventricular cells exhibit stable resting potentials and thresholds for activation near -55 mV. Moreover, the steady-state inactivation curves measured by Sakakibara and colleagues15 16 are such that INa would be completely inactivated (ie, no current available) at the resting potential. As pointed out by these authors, this is probably a result of time- and/or temperature-dependent shifts in the steady-state inactivation characteristics. Other results, such as the data from rabbit atrium published by Wendt et al17 (on which the INa description in the LMCG model is based) yield more positive (depolarized) steady-state activation and inactivation curves.

In developing a model of INa under physiological conditions, we have found it necessary to use indirect information about INa provided by action potential data in addition to voltage-clamp data. Thus, we have adjusted the steady-state activation curve (3) for INa so that the threshold at which an action potential is elicited agrees with experimental observations. Furthermore, the peak magnitude of INa was adjusted to match the maximum upstroke velocity of the action potential. (For a discussion of the relation between INa and action potential upstroke velocity, refer to Cohen and Strichartz.18 ) Fig 2ADown shows the steady-state activation (3) and inactivation () curves used to model INa. Compared with the data from human atrial myocytes obtained by Sakakibara et al15 (Fig 2ADown), there are significant positive shifts in both the 3 (+22.8 mV) and the (+32.2 mV) curves. Fig 2BDown shows a simulated peak current-voltage relationship (steps from a holding potential of -80 mV) for INa. The mathematical expressions for the kinetics of activation ({tau}m) and inactivation ({tau}h1 and {tau}h2) are very similar to those of the LMCG model, as shown in Figs 2CDown and 2DDown. The processes of inactivation and recovery from inactivation are both described by the sum of a fast and a slow exponential. At plateau potentials, the fast component of inactivation has a time constant of 0.3 ms. The slow component of inactivation accounts for 10% of the total current and has a time constant of 3.0 ms at plateau potentials; ie, it is 10 times slower than the fast component, in agreement with the data of Sakakibara et al.15



View larger version (23K):
[in this window]
[in a new window]
 
Figure 2. Parameters for INa. A, Steady-state activation (3) and inactivation () ({square} and {blacksquare} represent data from Sakakibara et al15 and dotted lines the expressions used in the LMCG model13 ). B, Simulated peak current-voltage relationship. C, Activation time constant ({tau}m). D, Inactivation time constants ({tau}h1 and {tau}h2).

L-Type Ca2+ Current: ICa,L
Several quite comprehensive studies of ICa,L in human atrial myocytes have been published.19 20 21 22 23 24 25 Overall, the results are quite consistent: ICa,L has an activation threshold near -40 mV, its peak at {approx}0 mV, and an apparent reversal potential of +50 to +60 mV. The current density for ICa,L varies considerably among these studies, however, and is also known to be reduced in diseased or dilated cells.22 26 Table 1Down shows published ICa,L densities compared with those used in the present model. The inactivation process for ICa,L is usually described as the sum of a fast and a slow component.19 20 21 22 23 In order to accurately measure the steady-state voltage dependence of inactivation, the duration of the "conditioning" prepulse in the voltage-clamp protocol (eg, see Li and Nattel25 ) must be at least four to five times the time constant of the slower component of inactivation. If the prepulse duration is shorter, the slower component will not have reached its steady state when the availability of current is measured (second voltage-clamp pulse), and inactivation will appear incomplete. Ouadid et al24 measured inactivation at room temperature (where the slower time constant exceeds 100 ms23) and found that inactivation was incomplete (U-shaped inactivation curve) when the prepulse duration was 150 ms but that it became more complete if the prepulse duration was increased to 400 ms. The data obtained by Li and Nattel at 36°C yield almost complete inactivation characteristics for a prepulse duration of 150 ms, consistent with faster kinetics at this temperature. However, these authors also note that prolonging the prepulse results in more complete inactivation curves. On the basis of these results, we have modeled inactivation of ICa,L as a process involving two components with different time constants but identical, fully inactivating, steady-state voltage dependence. This formulation differs from the LMCG model13 as well as the Luo-Rudy model,9 which both use a single (voltage-dependent) component of inactivation with incomplete steady-state voltage dependence.


View this table:
[in this window]
[in a new window]
 
Table 1. Peak ICa,L Values From the Literature Compared With the Model

Ouadid et al24 also report that the inactivation process is slowed considerably when Ba2+ is substituted for Ca2+ as charge carrier, indicating that inactivation is also Ca2+ dependent. This phenomenon is included in the Luo-Rudy model9 but not in the LMCG model.13 Our formulation differs from that of Luo and Rudy, however, in order to incorporate recent experimental results. First, there is now evidence that there exists a small restricted subsarcolemmal domain between the L-type Ca2+ channels and the peripheral junctional sarcoplasmic reticulum (SR) where Ca2+ concentration ([Ca2+]d) may transiently reach much higher levels than in the cytosol as a whole.27 This subsarcolemmal domain is not included in the Luo-Rudy model, which models Ca2+-dependent inactivation as a function of total cytosolic Ca2+ concentration. We have included such a subsarcolemmal domain and have modeled Ca2+-dependent inactivation as a function of [Ca2+]d. Second, there is recent evidence to suggest that [Ca2+]d modulates ICa,L inactivation by promoting a rapid mode of inactivation.28 29 Therefore, in our model, [Ca2+]d determines the fraction of L-type channels that are in the rapidly inactivating mode, ie, the ratio of the fast to slow components of inactivation discussed above. Thus, in this model, an experiment with Ba2+ as charge carrier shifted this equilibrium so that all L-type channels were in the slow mode. With Ca2+ as charge carrier, however, the equilibrium is shifted toward the faster mode of inactivation by an amount determined by [Ca2+]d. Hence, the inactivation of the total ICa,L follows a biexponential time course, where the relative contributions of the fast and slow exponentials are determined by [Ca2+]d. We have chosen to model this [Ca2+]d dependence as an instantaneous function of [Ca2+]d, assuming that the shift between the two modes is rapid compared with the diffusion of Ca2+ out of the restricted domain.

Fig 3ADown shows the steady-state activation (dL) and inactivation (fL) curves used to model ICa,L. Assuming that activation can be measured more accurately at room temperature than at physiological temperature, we have used the activation curve (dL) measured by Mewes and Ravens.23 However, in order to fit the voltage-clamp data (peak currents) of Li and Nattel25 (Fig 3BDown), we found it necessary to shift this activation curve by +3 mV. The expression for the inactivation curve (fL) is identical to that reported by Li and Nattel for human atrial myocytes at physiological temperature. Furthermore, the reversal potential for ICa,L is set to a constant value of +60.0 mV, as measured by Li and Nattel, rather than to the Nernst potential for Ca2+ ions. As shown in Fig 3BDown, the simulated peak current-voltage relationship (steps from a holding potential of -80 mV) agrees well with voltage-clamp data. Figs 3CDown and 3DDown show the time constants of activation ({tau}dL) and inactivation ({tau}fL1 and {tau}fL2) plotted against membrane voltage. We have used the inactivation and recovery time constant data obtained by Li and Nattel to formulate the expressions for {tau}fL1 and {tau}fL2 (see Fig 3DDown). These data were obtained in human atrial myocytes at physiological temperature. The expression for {tau}dL (Fig 3CDown) is similar to that of the LMCG model.



View larger version (22K):
[in this window]
[in a new window]
 
Figure 3. Parameters for ICa,L. A, Steady-state activation (L) and inactivation (L) curves. B, Simulated peak current-voltage relationship, normalized to peak current ({square} represents data from Li and Nattel25 ). C, Activation time constant ({tau}dL). D, Inactivation time constants ({tau}fL1 and {tau}fL2), with data from Li et al25 ({blacksquare}, recovery; {square}, inactivation).

Transient and Sustained Outward K+ Currents: It and Isus
Voltage-clamp experiments designed to study the outward currents responsible for repolarization in human atrial myocytes have identified a transient outward K+ current (denoted It), which activates rapidly on depolarization.1 30 In addition to this (Ca2+-independent) transient K+ current, a Ca2+-dependent transient outward current, which is activated by relatively large increases in [Ca2+]i, is sometimes observed.31 We have chosen not to include this Ca2+-dependent current, since it has never been observed in our experimental work. After It has decayed (inactivated), a more slowly inactivating, "sustained," outward K+ current (denoted Isus) is observed.2 22 32 33 The available data suggest that Isus is a separate current from It and that it is also carried mainly by K+ ions.2 34 35

The literature regarding the voltage dependence of It is somewhat inconsistent. In particular, the results regarding steady-state activation vary considerably. Shibata et al1 report a half-activation voltage (V1/2) of +1.0 mV for It in human atrium, whereas Näbauer et al,36 Wettwer et al33 (both in studies of human ventricle), and Le Grand et al22 (human atrium) report values of +16.7, +20.6, and +33.3 mV, respectively. These results seem unrealistic, since It is known to have a strong influence on early repolarization,1 2 and these values of V1/2 would result in only a small amount of It current being activated during a normal action potential (peak at +20 to +30 mV). Among the possible explanations for this variability in V1/2 are the sensitivity of this parameter to the concentration of divalent cations (Cd2+ and Co2+) used to block ICa,L33 37 and the possibility of a difference between human atrial and ventricular It. Therefore, we have based our model on the data of Shibata et al,1 which were recorded from human atrium in the presence of a low (100 µmol/L) [Cd2+]. The data regarding the voltage dependence of steady-state inactivation are also variable between different studies. Fig 4ADown shows the steady-state activation () and inactivation () curves used to model It. The curve is based on a fit to data from Shibata et al ({circ} in Fig 4ADown), and the curve is that reported by Firek and Giles.2 Time constants of activation ({tau}r) and inactivation ({tau}s) are plotted against voltage in Fig 4CDown and 4DDown, respectively. Data regarding the time constant of inactivation2 indicate that {tau}s is {approx}13 ms (at 33°C) at membrane voltages positive to 0 mV. At hyperpolarized potentials, the recovery of It from inactivation as measured in our laboratory appears to follow an exponential time course with a strongly voltage-dependent time constant, increasing from 15 ms at -100 mV to 387 ms at -60 mV. Our formulation for {tau}s is based on a fit to experimentally obtained recovery time constant values at negative potentials and inactivation time constant values at positive potentials. The recovery of It from inactivation in human atrial cells has been shown to be considerably more rapid than in rabbit atrial cells.2 38 As a result, It magnitude and action potential waveshape are much less rate dependent in human atrial cells.



View larger version (23K):
[in this window]
[in a new window]
 
Figure 4. Parameters for It and Isus. A, Steady-state activation and inactivation curves for It ( and , respectively) ({circ} represents data from Shibata et al1 ). B, Steady-state activation and inactivation curves for Isus (sus and sus, respectively) ({bigtriangleup} represents data from Wang et al35 ). C, Activation and inactivation time constants for It ({tau}r and {tau}s, respectively). D, Activation and inactivation time constants for Isus ({tau}rsus and {tau}ssus, respectively) ({bigtriangleup} represents data from Wang et al35 ).

Our model of Isus is based on the data of Wang et al.35 Fig 4BUp and 4DUp show the steady-state activation curve (rsus) and time constant of activation ({tau}rsus) for this current. On the basis of our recent data, we have also included a slow ({tau}{approx}300.0 ms) partial (40%) inactivation. The time constant for this inactivation process was obtained by fitting a biexponential function to the decaying outward current waveforms as described by Koidl et al.39 In addition to providing an estimate of {tau}ssus, this method also provides a more accurate separation of It and Isus than when Isus is estimated as the current at the end of the pulse.2 35 40 By combining our models of It and Isus, we are able to produce current waveforms closely resembling those recorded from human atrial myocytes in response to voltage-clamp pulses. Fig 5Down shows how It (panel A) and Isus (panel B) combine (panel C) to produce waveforms similar to experimental results (panel D). In our experience, the size of these currents varies considerably between individual cells, and as reported by Amos et al,40 there is also considerable variability in the ratio of It to Isus. The sizes of It and Isus in the model were chosen to provide good fits to action potential data and are well within this experimental variability. Table 2Down compares It and Isus densities reported in the literature with those used in this model.



View larger version (45K):
[in this window]
[in a new window]
 
Figure 5. It and Isus in response to the voltage-clamp protocol shown in the inset, normalized to cell capacitance. A, Simulated It waveforms. B, Simulated Isus waveforms. C, Sum of the It and Isus waveforms in panels A and B. D, Outward currents recorded from a human atrial myocyte.


View this table:
[in this window]
[in a new window]
 
Table 2. Values for It and Isus at +40 mV From the Literature Compared With the Model

Delayed Rectifier K+ Currents: IK,r and IK,s
Recent studies of the delayed rectifier K+ currents in human and rabbit atrial myocytes show that in both species the delayed rectifier current is generated by two distinct K+ conductances. These "rapid" (IK,r) and "slow" (IK,s) conductances have significantly different properties and can be separated experimentally on the basis of, for example, the sensitivity of IK,r, but not IK,s, to the antiarrhythmic drug E-4031.41 42 43 Since IK,s is believed to contribute only a small fraction of the total delayed rectifier current during a normal atrial action potential,41 one could produce an acceptable fit to nominal action potential data using a model incorporating only IK,r. However, because of the very slow activation characteristics of IK,s, this current would be expected to be more significant at high heart rates, where it could build up progressively from cycle to cycle as a result of residual activation, ie, failure to decay completely between cycles. Therefore, we have chosen to include both IK,r and IK,s in our model, thus enabling it to simulate specific effects of antiarrhythmic drugs on IK,r, the buildup of IK,s at elevated heart rates, and the resulting changes, such as those in action potential duration (APD) and refractory period.

Our model of IK,r is based on data from Wang et al,44 Muraki et al,41 and Sanguinetti et al.45 Figs 6ADown and 6CDown show the steady-state activation (a) and inactivation (i) curves and the time constant of activation ({tau}pa) compared with the available data. Since the inactivation of IK,r is very rapid compared with the activation, inactivation is modeled as being instantaneous. The expressions for IK,s are based on data recorded in human atrial myocytes by Wang and colleagues.42 44 Figs 6BDown and 6DDown show the characteristics of this current.



View larger version (24K):
[in this window]
[in a new window]
 
Figure 6. Parameters for IK,r and IK,s. A, Steady-state activation and inactivation curves for IK,r (a and i, respectively). Data are from Wang et al44 ({bigtriangleup}), Muraki et al41 ({circ}), and Sanguinetti et al45 ({square}). B, Steady-state activation curve for IK,s (). Data are from Wang et al44 ({bigtriangleup}). C, Activation time constant for IK,r ({tau}pa). Data are from Wang et al44 ({bigtriangleup}) and Muraki et al41 ({circ}). D, Activation time constant for IK,s ({tau}n). Data are from Wang et al44 ({bigtriangleup}).

In order to verify our model of IK,r we chose to simulate the "ramp clamp" experiment of Muraki et al41 in rabbit atrial cells (their Fig 7Down), in which the cell is subjected to an 0.8-V/s repolarizing ramp from an action potential peak potential down to -80 mV. This waveform is an approximation to the repolarization phase of an atrial action potential. The result (simulated response) is shown in Fig 7Down, along with data from Muraki et al. Note that the simulated waveform is very similar, although in order to fit action potential data, we have had to reduce the size of IK,r to 15% of that shown in Fig 7Down. Given that it is often difficult to detect any delayed rectifier current at all in most human atrial myocytes,2 it seems reasonable that this current should be assigned a very low density.



View larger version (14K):
[in this window]
[in a new window]
 
Figure 7. Current-voltage relationship for IK1 and IK,r normalized to peak IK1 ({approx}0.6 pA/pF) ({circ} and {bullet} represent data from Muraki et al41 ). The IK,r waveform is the response to an 0.8-V/s "ramp" repolarization from an action potential peak potential down to -80 mV.41

Time-Independent Currents: IK1, IB,Na, IB,Ca, INaK, INaCa, and ICaP
In the absence of reliable published data from human atrial cells for these currents, we have used expressions from the LMCG model13 with only minor scaling adjustments. One exception is the inward rectifier current, where we have found it necessary to make minor modifications to the rectifying characteristics in order to fit action potential data (slightly narrower outward "hump"). We have also adjusted the [K+]c dependence of IK1 to agree with data from our laboratory. Table 3Down lists the changes made in the time-independent currents compared with those in the LMCG model.


View this table:
[in this window]
[in a new window]
 
Table 3. Time-Independent Current Formulations Compared With the LMCG Model

Material Balance
As in the LMCG model,13 we have included a fluid compartment formulation to monitor and account for changes in ion concentrations. These concentration changes can be a result of current flow across the cell membrane or of redistribution of ions within the cell (eg, uptake of Ca2+ by the SR or binding of Ca2+ to an intracellular buffer). Our fluid compartment model is similar to the one in the LMCG model. It includes descriptions of extracellular and intracellular spaces, formulations for Ca2+ uptake and release and the buffering action of calsequestrin, and troponin and calmodulin buffers in the intracellular medium. Compartment volumes and other ultrastructural properties, as well as expressions describing the binding of Ca2+ to intracellular troponin and calmodulin buffers and to calsequestrin in the SR release compartment, are identical to those of the LMCG model, except as noted in the following sections.

Cleft Space
We have included a "cleft space" in our fluid compartment formulation, ie, a small restricted space surrounding the cell, in which accumulation or depletion of ions may occur (see Demir et al12 ). The cleft space is modeled as an unstirred fluid layer; ie, ions can be exchanged between the cleft space and the extracellular medium (in which all concentrations are assumed constant) only through diffusion as a result of a concentration gradient. Ratios between diffusion time constants for the ions involved ({tau}Na, {tau}K, and {tau}Ca) were calculated from values for ionic conductivity46 and the composition of the extracellular solution ([Cl-]o=140 mmol/L, [Na+]o=130 mmol/L, [K+]o=5.4 mmol/L, and [Ca2+]o=1.8 mmol/L). We have adjusted the size and diffusion properties of the cleft space so as to produce oscillations in cleft space [K+] ([K+]c) similar to experimental data.47 48

Electroneutral Na+ Influx
In order to achieve long-term stability in the ionic concentrations in the model, we have found it necessary to add a small (1.68-pA) electroneutral inward flux of Na+, denoted {Phi}Na,en. This flux could, for example, be accounted for in terms of electroneutral coupled transport mechanisms, such as Na+-H+ exchange and Na+-K+-2Cl cotransport. Modeling of these mechanisms, however, is beyond the scope of this work.

There are two major reasons for including this flux: First, the fact that long-term ionic homeostasis can be achieved with the addition of this small flux demonstrates that the sizes and other characteristics of the model elements are such that ionic homeostasis can reasonably be maintained. Second, if the ionic concentrations were allowed to change slowly from cycle to cycle (which would be the result if this flux were not included), the model would only be valid for short simulation times (seconds), for which this drift can safely be ignored. By ensuring long-term stability of the ionic concentrations, longer simulation times (minutes) become feasible and meaningful. Only with stable ionic concentrations can the model be used to simulate concentration changes as a result of rate changes or other interventions.

Sarcoplasmic Reticulum
Our formulation for the SR is very similar to that of the LMCG model. However, we have made one important modification in accordance with recent evidence demonstrating that Ca2+ can accumulate in a small domain between the sarcolemma and the peripheral junctional SR and trigger Ca2+ release.27 49 Specifically, we have removed the voltage-dependent term in the formulation for activation of SR Ca2+ release and replaced it with a term dependent on Ca2+ concentration in the restricted subsarcolemmal domain, [Ca2+]d. The sole mechanism for SR Ca2+ release in our model is therefore Ca2+-induced Ca2+ release (CICR). Fig 1BUp includes a schematic representation of the model of the SR.

Stern50 has shown that in order for a CICR model to be stable, ie, capable of producing a response that is graded by the amount of Ca2+ that enters the cell through ICa,L, the trigger Ca2+ has to be separated from that released from the SR. Anatomically, this can be understood in terms of the concept of "release units" discussed, for example, by Isenberg and Han.51 According to this concept, Ca2+ release from the SR is recruited stepwise by the all-or-none activation of individual release units, consisting of one or more L-type Ca2+ channel and associated SR release channels. The activation of a release unit results in CICR within that unit only. The released Ca2+ then diffuses into the myoplasm, without directly affecting other units. This phenomenon has been incorporated in our model as a lumped mechanism, where the SR release channel senses [Ca2+] in the restricted domain ([Ca2+]d) but releases Ca2+ directly to the cytosol (Fig 1BUp), thus separating trigger Ca2+ from that released from the SR.

Parameter Values
A model of this type contains a large number of parameters that must be assigned values based on the available data. We have approached this part of the model development process in a two-step fashion, where the majority of the parameter values have been assigned in the first step, based on experimental studies of individual model components. This has the advantage that most of the parameters associated with an individual membrane current can be justified and assigned independently. Once the descriptions of individual membrane currents has been completed, one is left with a limited number of free parameters, most of which are scaling factors, such as the maximum conductance values for each ionic current. These remaining free parameters can then be determined using data for whole-cell responses (eg, action potential waveforms) or other constraints as indicated previously (eg, ionic homeostasis). It should be emphasized, however, that model development is very much an iterative process and that it has been necessary in some cases to modify individual current expressions to obtain acceptable fits to action potential data or (as in the case of INa) to use information from action potential recordings to resolve ambiguities in ion channel current data. The following sections describe the constraints and criteria used in order to assign values for the remaining free parameters.

The Quiescent Human Atrial Myocyte
In the absence of an external stimulus, a healthy human atrial cell is quiescent (does not contract or produce an action potential). In this quiescent state, the membrane potential comes to an equilibrium, "resting," potential at which the net ion flux across the sarcolemma is zero. The resting membrane potential varies somewhat among individual cells, ranging from -70 to -80 mV. The resting membrane potential is the result of a precise balance between the time-independent background, pump, and exchanger currents (IK1, IB,Na, IB,Ca, INaK, ICaP, and INaCa). Although the resting state of the cell may seem less interesting than the active state during an action potential, an accurate description of the resting conditions is, in our experience, essential for successful modeling of the action potential. Moreover, the model of the resting state of the cell determines very important threshold characteristics and subthreshold properties, such as the input resistance of the cell. Very accurate simulation of these passive characteristics is essential before the cell model is to be used in distributed simulations, eg, of the propagation of electrical activity from one cell to another. We have modeled the resting state of the cell by adjusting the magnitudes of these currents so as to produce zero net transmembrane current at a resting potential of {approx}75 mV and the following intracellular ion concentrations: [Na+]i{approx}8.5 mmol/L; [K+]i{approx}130.0 mmol/L, and [Ca2+]i{approx}60.0 nmol/L. The input resistance of the cell in this quiescent state is {approx}600 M{Omega}, which agrees with our experimentally observed values.

The Activated Human Atrial Myocyte
When the cell is stimulated, it produces an action potential, the shape of which depends on the relative sizes of the ionic currents involved. Action potential data recorded from isolated human atrial myocytes are (in our experience) quite variable from cell to cell. It is therefore questionable whether it is possible to define the "normal human atrial action potential" in a meaningful way. We have chosen to fit our model to an action potential waveform that is representative of what is most often recorded from isolated human atrial cells in our laboratory. By establishing this "nominal model," we have obtained a starting point from which the sensitivity of the action potential waveform to parameter perturbations may be studied (see "Results"). In addition to dictating the action potential waveform, the sizes (maximum conductance parameters) of the ionic currents also affect ionic homeostasis. The membrane currents involved in shaping the action potential therefore have to act in concert with those involved in the resting state to maintain constant ion concentrations at nominal stimulation rates. We have "tuned" our model so that ion concentrations remain constant from cycle to cycle at a stimulus frequency of 1 Hz.


*    Results
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
*Results
down arrowDiscussion
down arrowAppendix 1
down arrowAppendix 2
down arrowReferences
 
There are two major aims of the simulations presented in the following sections: (1) to establish the validity and usefulness of our model by demonstrating that the expressions that are based on fits to voltage-clamp data for individual ionic currents also are able to accurately reconstruct action potential data and (2) to use the model to investigate the functional roles of different ionic currents, to study the sensitivity of the action potential waveform to the sizes of those currents, and, finally, to predict the whole-cell response to, for example, selected channel blocking drugs.

Simulated Action Potential Waveform
Fig 8ADown shows a simulated action potential waveform (solid line) compared with an action potential (dotted line) recorded at a temperature of 33°C and a stimulus frequency of 0.5 Hz. There is close agreement between the waveforms (the discrepancy at the beginning of the upstroke is due to a stimulation artifact that is not simulated). As mentioned previously, the action potential waveform varies significantly among individual cells and in multicellular preparations from the human atrium, presumably because of variations in the magnitudes of the underlying ionic currents. Nevertheless, the ability of this model to accurately reproduce a recorded action potential, in combination with the previously demonstrated fits to voltage-clamp data, lends credibility to the model.



View larger version (28K):
[in this window]
[in a new window]
 
Figure 8. Model-generated action potential and membrane current waveforms. A, Model-generated action potential (solid line) compared with recorded data (dotted line). B and C, Model-generated waveforms for the ionic currents during the action potential (note the difference in scale between panels B and C).

In Fig 8Up, panels B and C show the behavior of the membrane currents during an action potential. The first current to respond to a depolarizing stimulus pulse (delivered at time=100 ms) is INa, which activates rapidly, resulting in a very large but transient inward current. Note that INa is too large to be shown on the scale of Fig 8BUp; its peak magnitude is {approx}-5.8 nA, which corresponds to a maximum upstroke velocity of 116 V/s. INa is primarily responsible for the upstroke (phase 0) of the action potential, but as seen from Fig 8BUp, a substantial amount of INa remains during the early peak phase of the action potential as a result of the second slower component of INa inactivation.

On depolarization of the cell, It, Isus, and ICa,L are also activated. However, It and Isus reach their peak magnitude faster than ICa,L, and their combined magnitude is thus larger than that of ICa,L early in the action potential. (This is because the peak of the action potential is close to the reversal potential for ICa,L.) The initial result on the action potential waveform is therefore a period of relatively rapid repolarization (phase 1), dominated by It. Since the time course of inactivation of ICa,L is slow compared with that of It, the net current gradually becomes dominated by ICa,L and Isus. A situation where the repolarizing effect of Isus (and the remaining It) is balanced by the depolarizing effect of ICa,L results. In the action potential waveform, the initial rapid repolarization (phase 1) is followed by a period during which the membrane potential levels off, forming a plateau (phase 2). Finally, as ICa,L slowly inactivates, the repolarizing effects of Isus become dominant, and the action potential enters its final repolarization phase (phase 3). During this phase, Isus is aided by the inward rectifier current, IK1, and the delayed rectifier currents, IK,r and IK,s, in repolarizing the cell membrane back to the resting potential (phase 4).

Simulated Ionic Fluxes
The fluid compartment part of this model monitors ion concentrations in the intracellular and cleft spaces. Valid modeling of the action potential requires not only the reconstruction of the action potential waveform but also a demonstration that this can be accomplished under conditions of ionic homeostasis at nominal heart rates. Table 4Down shows how our model has been tuned to achieve homeostasis at 1 Hz. The average charge transported across the sarcolemma for each ionic current has been computed by integrating each current over one cycle (1 s in the case of a quiescent, nonstimulated cell). Note that the sums of these average charges are zero for all ionic species at a stimulus rate of 1 Hz (Table 4Down). When the cell is quiescent, there is a small net loss of intracellular Na+ and gain of intracellular K+. The existence of such an ionic imbalance at quiescence is supported by the observation by Bénardeau et al52 that trains of depolarizing pulses that activate INa can be used to hyperpolarize the resting potential of human atrial cells after a period of quiescence. As suggested by these authors, the hyperpolarization and stabilization of the resting potential may be caused by activation of the Na+-K+ pump after Na+ entry during the train of pulses. In our model, at a 2-Hz stimulus rate there will be a net gain of intracellular Na+ and loss of K+.


View this table:
[in this window]
[in a new window]
 
Table 4. Current Integrals Over 1 s at Quiescence and at Stimulus Rates of 1 and 2 Hz

Fig 9Down illustrates the Ca2+ handling in the fluid compartment part of the model during the simulated action potential. A transient increase in [Ca2+]i occurs early in the action potential, raising [Ca2+]i from the very low diastolic levels ({approx}65 nmol/L) to a peak of {approx}1.3 µmol/L (Fig 9BDown). This rise in [Ca2+]i is primarily due to the rapid release of large amounts of Ca2+ from the SR (see Fig 9DDown). Several processes are responsible for the decline of the intracellular Ca2+ transient. The most potent of these is the rapid binding of Ca2+ to the intracellular Ca2+ buffers (troponin and calmodulin), which is particularly important in shaping the early portions of the Ca2+ transient. As seen in Fig 9CDown, the occupancies on these buffers increase rapidly as Ca2+ is released from the SR, thus "removing" large amounts of free Ca2+ from the cytosol. The uptake of Ca2+ by the SR also has a pronounced effect on the shape of the Ca2+ transient. This is also the primary pathway for actual removal of Ca2+ from the cytosol (as opposed to the "temporary storage" provided by the buffers), taking up intracellular Ca2+ as it dissociates from the buffers. In addition, some Ca2+ is removed from the cytosol via the Na+-Ca2+ exchanger, INaCa, and the Ca2+ pump, ICaP. As seen in Table 4Up, INaCa and ICaP, on average, remove the amounts of Ca2+ that were brought into the cell via ICa,L and IB,Ca and thereby prevent a progressive buildup of cytosolic Ca2+ during repetitive stimulation.



View larger version (31K):
[in this window]
[in a new window]
 
Figure 9. Simulated waveforms for the fluid compartment model. A, Action potential waveform. B, Intracellular Ca2+ concentration, [Ca2+]i. C, Occupancies of the troponin (OTC and OTMgC), calmodulin (OC), and calsequestrin (OCalse) buffers. D, Sarcoplasmic reticulum release and uptake currents (Irel and Iup, respectively). E, Ca2+ concentrations in the sarcoplasmic reticulum release and uptake compartments ([Ca2+]rel and [Ca2+]up, respectively).

Increasing the stimulus rate from the baseline (1 Hz) results in a change in ion concentrations in the intracellular medium (Table 4Up) as well as in the cleft space surrounding the cell. For the ionic species that exist in relatively low concentrations in the extracellular medium (Ca2+ and K+), these changes can be significant. Fig 10Down shows how the intracellular and cleft space concentrations change when the stimulus rate is increased abruptly from 1 to 2 Hz. Note the progressive shift in [K+]c of {approx}1 mmol/L.47 48 In contrast, the change in [Na+]c is negligible because of its high baseline value of 130 mmol/L. If the simulation in Fig 10Down is continued beyond the 20 s shown, [K+]c will reach a peak value of {approx}6.3 mmol/L, after which it will begin to decline as a result of increased INaK activity due to increased [Na+]i and [K+]c (simulation not shown). The asymptotic values for [K+]c and [Na+]i are 5.6 and 10.0 mmol/L, respectively (reached after {approx}10 minutes). This behavior is consistent with experimental observations.47



View larger version (43K):
[in this window]
[in a new window]
 
Figure 10. Ion concentrations in the intracellular and cleft spaces when the stimulus rate is increased from 1 to 2 Hz. A, Action potential waveform. B, Cleft space K+ concentration, [K+]c. C, Cleft space Ca2+ concentration, [Ca2+]c. D, Intracellular Na+ concentration, [Na+]i. E, Intracellular K+ and cleft space Na+ concentrations, [K+]i and [Na+]c.

Parameter Sensitivity of the Action Potential Shape
As mentioned in the previous section, there is considerable variation in action potential shape among individual cells from the human atrium. Our working hypothesis is that many of these differences in action potential waveshape can be explained in terms of differences in the magnitudes of the ionic currents (caused by previous drug treatment and/or natural variability). In order to investigate possible mechanisms of action potential shape variability, it is therefore necessary to have an understanding of how changes in the magnitudes of different ionic currents affect the action potential shape. Such an understanding is equally important, of course, in identifying suitable "targets" for drug action aimed at modifying the action potential shape.

A valid mathematical model provides a method for this sensitivity analysis53 ; ie, it provides a method for studying how sensitive the state variables (eg, membrane voltage) are to perturbations in model parameters. We will restrict this analysis to a study of the sensitivity of the action potential waveform to changes in the sizes (maximum conductances) of the currents involved in shaping the action potential, although this type of analysis in principle can be used to study the sensitivity of any state variable to perturbations in any model parameter. Briefly, sensitivity analysis involves the computation of the partial derivative of the state variable of interest (in this case, membrane voltage) with respect to a model parameter. We have chosen to normalize these partial derivatives with respect to the nominal value of each parameter. Thus, we will present the results in terms of sensitivity functions, defined as:

which can be interpreted as a proportionality factor relating a relative change in a model parameter to a resulting change in membrane voltage. The computational aspects of this method are outlined in Appendix B (see also Paulsen et al53 ).

Fig 11Down shows the result of the sensitivity analysis, ie, the sensitivity functions for the membrane voltage (action potential) with respect to the parameters of interest. Sensitivity functions were computed for all maximum conductance parameters in the model as well as for the scaling parameters for INaK and INaCa. The sensitivity functions for INa and IK,s have been omitted from Fig 11Down, since these currents were found to have negligible influence on the action potential shape (small sensitivity functions), except for the obvious importance of INa during the upstroke. Several of the sensitivity functions have maximum absolute values of {approx}50 mV during the late repolarization phase of the action potential. In other words, a 10% change in either one of these parameters would alter the membrane voltage by {approx}5 mV during this phase of the action potential. Although this estimate is based on a linearization around the nominal parameter value and thus is most accurate for small perturbations, it can provide an indication of the approximate change expected for larger perturbations. Overall, we can anticipate that changes in these parameters in the ±50% range will produce significant changes in the action potential waveform.



View larger version (29K):
[in this window]
[in a new window]
 
Figure 11. Results of the sensitivity analysis. A, Nominal action potential waveform. B, Sensitivity functions (for the action potential waveform) with respect to scaling factors for outward currents (t, sus, K1, INaK, and K,r). C, Sensitivity functions with respect to scaling factors for inward currents (Ca,L, B,Na, B,Ca, and kNaCa).

Perhaps more important than the absolute sensitivity values, however, is the information provided by the time course of the sensitivity functions. As the ionic conductances change during the action potential, the sensitivity functions indicate which currents have the greatest influence on the action potential shape at each point in time. For example, it is clear that the action potential waveform is sensitive to t primarily early in the peak phase of the action potential but that sus and Ca,L rapidly become more important early in the plateau phase. Throughout the plateau phase, |{epsilon}sus| (absolute value) and |{epsilon}Ca,L| are larger than |{epsilon}t|, and this portion of the action potential waveform is therefore particularly sensitive to perturbations in sus and Ca,L. Toward the end of repolarization, the action potential becomes very sensitive to the size of the time-independent currents involved in maintaining the resting potential. This analysis shows that (under the hypothesis that action potential changes can be explained in terms of changes in the magnitudes of ionic currents) t, sus, and Ca,L are the most important model parameters in determining the action potential waveshape during the peak and plateau phases of the action potential.

Roles of It and Isus in Repolarization
The effects on the human atrial action potential of blocking It with agents such as 4-aminopyridine, flecainide, and quinidine have been described in the literature.2 54 55 56 Partial block of It results in a slowing of the rate of repolarization of the action potential, particularly during the early repolarization phase (phase 1). This is, of course, consistent with the characteristics of It, and its role in the generation of the action potential as indicated by sensitivity analysis. In a recent study of the effects of some antiarrhythmic agents on It and Isus, Wang et al56 found that quinidine, in addition to blocking It, has a pronounced effect on Isus at clinically relevant concentrations. Considering that our sensitivity analysis indicates a prominent role for Isus in repolarization, the APD is expected to be quite sensitive to modulation of Isus magnitude. A detailed account of the role of It and Isus in the repolarization of the human atrial action potential is therefore essential for understanding the antiarrhythmic actions of quinidine.

Since pharmacological blocking agents used in experimental work usually affect more than one current and since their effects are often rate dependent, it is difficult to gain a quantitative understanding of the importance of a particular current (It or Isus) in repolarization from experimental results alone. In a computer model, however, it is possible to alter the characteristics of one ionic current in a controlled fashion, while leaving all other currents unaffected. Such simulations can be a valuable complement to experimental work. Given that drugs that prolong the APD (class III drugs) have been shown to be effective in the treatment of atrial arrhythmias,57 a thorough understanding of the influence of different ionic currents on the APD is needed.

Fig 12ADown shows the effects on the action potential of various degrees (30%, 60%, and 90%) of block of It. (In the present study, an x% block of It is simulated as an x% reduction in the maximum conductance, t.) As observed experimentally, It block results in a broadening of the action potential peak during phase 1 of repolarization (refer to Fig 2 in Firek and Giles2 ). In addition, because of the elevation of the action potential peak and plateau levels, the contribution of Isus to repolarization is increased. The resulting prolongation of the APD is therefore only moderate, even for substantial reductions of It size. Fig 12BDown shows the effects of various degrees (15%, 30%, and 45%) of block of Isus on the action potential. In contrast to It block, inhibition of Isus primarily affects the plateau phase of the action potential, with little or no effect on the action potential peak. As a result, Isus block produces a more pronounced prolongation of the APD than does It block. For example, 30% block of Isus results in a 15% increase in APD at 90% repolarization (APD90) compared with the 5% increase in APD90 resulting from 30% It block. Many antiarrhythmic agents have effects on several ion channels. For example, according to Wang et al,56 quinidine blocks both It and Isus (in addition to its effects on Na+ channels). It is therefore of interest to study the effects on the action potential of combined It and Isus block. Fig 12CDown shows the result of a simulation in which both It and Isus have been reduced by 40% (approximately corresponding to the effect of 5 µmol/L quinidine at a stimulus rate of 1 Hz56). As expected, the result is essentially a combination of the previously demonstrated effects of It and Isus block, ie, a widened peak, an elevated action potential plateau, and a prolongation of APD90 of 27%.



View larger version (33K):
[in this window]
[in a new window]
 
Figure 12. Effects of partial block of It and Isus. A, It block (30%, 60%, and 90%) has its main effect on the peak and produces only a moderate prolongation of the action potential. B, Isus block (15%, 30%, and 45%) has a strong effect on the action potential duration. C, Combined block (40%) of It and Isus widens the peak and prolongs the action potential, in a way similar to the effect of 4-aminopyridine (4-AP). D, Recorded action potential under control conditions and in the presence of 4-AP (data from Firek and Giles2 ).

Modulation of the Role of Isus by Baseline ICa,L, Isus, and IK,r Sizes
As discussed in "Model Development," published data regarding the size of ICa,L and Isus are quite variable. Both these currents (as well as It) are known to be depressed in diseased human atrial cells22 26 and modulated by adrenergic stimulation.26 58 Furthermore, a recent study59 shows that the size of Isus is significantly reduced in cells obtained from patients in chronic atrial fibrillation compared with patients in normal sinus rhythm. It is therefore likely that a range of sizes of these two currents contributes to the physiological (and pathophysiological) behavior of the human atrial cell. Similarly, IK,r in our nominal model is very small, which is consistent with observations from our laboratory. Since results in other species60 indicate that this may be a consequence of the cell isolation techniques used for human atrial myocytes,2 this current may be considerably larger in vivo. Given these uncertainties in the actual sizes of several of the ionic currents, it is appropriate to investigate how the conclusions reached above are affected by our assumptions for these current sizes. We have chosen to focus on the role of Isus in repolarization, since this current is an important determinant of APD. Starting from our nominal model, we have performed a large number of simulations for different combinations of increased/decreased ICa,L, Isus, and IK,r. All simulations were performed at a stimulation rate of 1 Hz, and 20 cycles were allowed after each change of parameter values in order for any initial transient behavior to die out before the APD prolongation was evaluated. Fig 13Down shows how the APD prolongation resulting from a 50% reduction of Isus depends on the baseline sizes of ICa,L and IK,r. ICa,L and IK,r sizes are expressed as percentages of those in the nominal model; ie, the nominal model corresponds to 100% of both currents. A 7-fold (700%) increase in IK,r corresponds approximately to the size of IK,r observed in rabbit atrial myocytes.41 It is clear from Fig 13Down that the role of Isus as a major determinant of APD depends strongly on the size of IK,r current. The action potentials shown in the insets in Fig 13Down provide an indication of the underlying mechanism. When Isus is partially blocked, the action potential plateau is depolarized, which in turn increases the amount of IK,r (and IK,s) that is activated. This effect, which counteracts the APD-prolonging effect of Isus block, becomes stronger as the size of IK,r is increased. Similarly, Fig 14Down shows how the APD prolongation as a result of 50% Isus block depends on the baseline sizes of ICa,L and Isus. Again, the APD-prolonging effect of Isus block is strongly dependent on the baseline current densities. Generally, the APD prolongation as a result of partial Isus block becomes larger as the baseline size of ICa,L increases, provided that the increase in ICa,L is balanced by a comparable increase in Isus. Notice, however, in Fig 13Down as well as in Fig 14Down, that when baseline ICa,L is increased without such a comparable increase in baseline outward current (Isus or IK,r), the APD-prolonging effect of Isus block is instead reduced. The underlying mechanism in this case is that the action potential plateau, both before and after Isus block, is prolonged and depolarized somewhat by the larger ICa,L. As a result, more IK,r (and IK,s) is activated, and the final repolarization phase becomes steeper and therefore less dependent on Isus.



View larger version (62K):
[in this window]
[in a new window]
 
Figure 13. Prolongation of action potential duration at 90% repolarization (APD90) as a result of 50% reduction of Isus size, plotted as a function of the baseline ICa,L and IK,r sizes. (100% denotes the nominal sizes of ICa,L and IK,r.) Insets show examples of action potentials (before and after Isus block) corresponding to three points in the graph (middle inset is for the nominal model).



View larger version (58K):
[in this window]
[in a new window]
 
Figure 14. Prolongation of action potential duration at 90% repolarization (APD90) as a result of 50% reduction of Isus size, plotted as a function of the baseline ICa,L and Isus sizes. Insets show examples of action potentials (before and after Isus block) corresponding to three points in the graph (middle inset is for the nominal model).


*    Discussion
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
*Discussion
down arrowAppendix 1
down arrowAppendix 2
down arrowReferences
 
Mathematical models form an important complement to experimental work in attempts to elucidate the ionic mechanisms underlying the action potential and other electrophysiological phenomena in cardiac cells. At a minimum, these models can provide a means of integrating data obtained from many different experiments and laboratories so that biophysically based explanations of complex nonlinear phenomena such as action potential initiation (excitation) and repolarization can be given. Mathematical models also provide a way of reviewing data in the context of the normal behavior of a cell (during an action potential), even when some of the data may have been obtained under completely different experimental conditions, eg, a voltage-clamp experiment. Moreover, as illustrated in the last few sections of "Results," mathematical models can also have considerable predictive capabilities. After a model has been developed and carefully validated, it can be used to predict the response of the cell to selected drugs, experimental protocols, etc. Ideally, experimental work and model development should be carried out in close association, using the model to design and evaluate experiments and using experimental results to improve the model.

We have developed a mathematical model of the human atrial cell based primarily on data recorded from enzymatically isolated single human atrial cells. Our model is capable of accurately reconstructing a recorded human atrial action potential and illustrates the functional roles of the ionic currents. In addition, our model maintains ionic homeostasis at a nominal stimulus rate, demonstrating that the reconstruction of the action potential is accomplished using plausible current densities. We used the LMCG rabbit atrial model13 as a "starting point" for the model development. As a result, these two formulations are very similar in some aspects, particularly for the membrane currents where incomplete (or no) data from human atrial cells are available. However, there are some important differences between the electrophysiological responses of rabbit and human atrial cells; these provided the motivation for the development of this human atrial cell model. Perhaps most striking is the small rate dependence of It in human atrial cells compared with the very prominent rate dependence seen in rabbit atrial cells.13 38 This is mainly due to differences in the rates of recovery from inactivation of It in the two species. As discussed in "Membrane Currents," It in human atrial cells recovers from inactivation much more rapidly than does It in rabbit atrial cells. Another important difference between human and rabbit atrial cells is the sustained outward current (denoted Isus in this article). Whereas this current in the rabbit atrium is believed to be carried mainly by Cl- ions,13 there is convincing evidence that Isus in human atrial cells is carried mainly by K+ ions.2 35 Both these differences are very important in studying the mechanisms of repolarization of the human atrial action potential and the effects of action potential–prolonging (class III) drugs that affect these currents.

Roles of It and Isus in Repolarization
Both It and Isus have important roles in the repolarization of the action potential of human atrium. In particular, Isus, because of its noninactivating characteristics, is necessary for repolarization to the resting potential. This important role in repolarization makes It and Isus potential targets for class III antiarrhythmic drugs, which are designed to prolong the APD. Indeed, a recent study of flecainide and quinidine,56 both known to prolong the human atrial action potential,54 55 shows that both these drugs produce a partial block of It. Quinidine also blocks Isus, which could explain its greater efficacy (compared with flecainide) in prolonging the APD.55 Our simulations of partial It and Isus block (see "Results") produce prolongations of the APD that are comparable to experimentally observed effects of flecainide and quinidine, ie, a 27% prolongation of APD90 when It and Isus are both reduced by 40%. For comparison, Wang et al55 reported that 2.25 µmol/L quinidine increased APD95 by 33% in human atrial cells at a stimulation rate of 1 Hz. It should be noted that only some of the known effects of quinidine have been modeled; therefore, our results cannot be directly compared with these experimental observations. For example, the effects of quinidine on INa, as well as the state dependence of It block by quinidine,61 would have to be included in a more comprehensive treatment of quinidine effects. Nevertheless, the experimental observations agree very well with our model predictions and provide an independent "test" of how well our model describes the roles of It and Isus in repolarization.

Action potential generation involves a complex interaction among the ionic currents in a given cell type. The role of a particular ionic current in the action potential is therefore not determined solely by the characteristics of that current. We have investigated how the role of Isus in repolarization is affected when the baseline densities of ICa,L, Isus, and IK,r are varied within ranges that are relevant to the physiological and pathophysiological behavior of the human atrial cell. Our results demonstrate that Isus block will, in general, result in a prolongation of the action potential. The amount of prolongation, however, depends quite strongly on the baseline current densities. If the human atrial cell is assumed to have an IK,r density comparable to that observed in the rabbit atrium41 or if the ICa,L and Isus densities are reduced as observed in diseased cells,22 26 the APD prolongation resulting from Isus block may be considerably smaller than indicated by our nominal model. The efficacy of a drug targeting Isus would therefore be expected to depend critically on the disease state of the tissue. For example, based on the recent observation by Van Wagoner et al59 that Isus density is reduced in cells obtained from patients in chronic atrial fibrillation, the efficacy of an Isus-blocking drug may be limited in these patients.

Limitations of the Model
When using our model to gain insight into the electrophysiological responses of the human atrial cell, it is important to be aware of certain limitations, which are summarized by the following items:

1. The Hodgkin-Huxley formalism along with its concept of independent activation and inactivation "gating" variables has some important limitations. Notably, the processes of inactivation and recovery from inactivation (and analogously activation and deactivation) are governed by a single time constant. Experimental observations, however, often indicate that inactivation and recovery from inactivation occur with different time constants, even at the same membrane potential. In order to overcome this problem, one would have to use a more complicated modeling formalism that treats inactivation and recovery as two separate processes. To reduce the computational requirements of the model, we have chosen a "compromise" solution, in which time constant values are determined by measured inactivation kinetics at depolarized membrane potentials and by measured recovery kinetics at hyperpolarized potentials. In cases in which the time constants of inactivation and recovery are very different, this compromise results in unconventional time constant expressions, such as those for INa in Fig 2DUp.

2. The available data regarding the intracellular Ca2+ transient and the Ca2+ handling in the SR have, with few exceptions,52 62 been recorded in cells from species other than humans. In addition, the understanding of the exact mechanisms involved in these phenomena is incomplete, and a quantitative model of SR Ca2+ release and uptake has not yet been developed. Our Ca2+-dependent formulation for SR Ca2+ release replaces the voltage-dependent formulation used in earlier models4 12 13 but is nevertheless only a qualitative description of this phenomenon. Other features of the SR function are the same as those in the LMCG model.13 Our SR formulation is therefore not based on human data.

3. The shape of the action potentials recorded from enzymatically isolated human atrial cells is variable, even at a fixed stimulus frequency. There are several reasons for this variability, including genuine heterogeneity between cells from different parts of the atrium, the disease states of the patients from whom the specimens are obtained, and the use of various drugs (eg, Ca2+ channel blockers and ß-blockers) by the donors. It is important to acknowledge that this variability exists and that the exact action potential waveform in the model is chosen because it is representative of the action potential shapes that are most often observed in our single cell records. As indicated by sensitivity analysis, the shape of the human atrial action potential as described by our model is quite sensitive to variations in the strengths of three ionic currents (It, Isus, and ICa,L). Under the assumption that the currents involved and their kinetic properties are unchanged, our results therefore suggest that the experimentally observed variation in action potential shape is caused mainly by variations in these currents and can be explained within the framework of our model. However, it is also conceivable that regional diversity in the molecular basis of the currents in human atrium could give rise to regional differences in kinetics and pharmacological sensitivity. Most of the data on human atrial electrophysiology to date have been obtained from samples of the atrial appendage, and there are therefore little experimental data available regarding regional differences in human atrium. If and when data to suggest regional diversity become available, our model should provide a useful framework for predicting the consequences.

4. Our model of Ca2+-dependent inactivation of ICa,L uses a single lumped subsarcolemmal compartment in which Ca2+ accumulates and is therefore limited in its ability to simulate the effect of Ca2+ accumulation in restricted spaces close to each L-type Ca2+ channel. In contrast to voltage-dependent gating, where it is reasonable to assume that the controlling variable (membrane voltage) is spatially uniform (space-clamp conditions), this is in all likelihood not the case for subsarcolemmal Ca2+. Since inactivation is a nonlinear function of [Ca2+]d, it is not strictly correct to use a formulation in which all channels are subject to one (average) Ca2+ concentration.

Notwithstanding these limitations, this model provides the most complete description available of the ionic mechanisms underlying the human atrial action potential, and it is based on the available data. As a result, it provides a very useful tool for investigating fundamental electrophysiological responses of the human atrial cell, such as excitability, refractoriness, and the action of channel blocking drugs.


View this table:
[in this window]
[in a new window]
 
Table 5. Membrane Voltage: V


View this table:
[in this window]
[in a new window]
 
Table 6. Na+ Current: INa


View this table:
[in this window]
[in a new window]
 
Table 7. Ca2+ Current: ICa,L


View this table:
[in this window]
[in a new window]
 
Table 8. Transient and Sustained Outward K+ Currents: It and Isus


View this table:
[in this window]
[in a new window]
 
Table 9. Delayed Rectifier K+ Currents: IK,s and IK,r


View this table:
[in this window]
[in a new window]
 
Table 10. Inward Rectifier K+ Current: IK1


View this table:
[in this window]
[in a new window]
 
Table 11. Background Inward Currents: IB,Na and IB,Ca


View this table:
[in this window]
[in a new window]
 
Table 12. Pump and Exchanger Currents: INaK, ICaP, and INaCa


View this table:
[in this window]
[in a new window]
 
Table 13. Intracellular Ion Concentrations: [Na+]i, [K+]i, and [Ca2+]i


View this table:
[in this window]
[in a new window]
 
Table 14. Cleft Space Ion Concentrations: [Na+]c, [K+]c, and [Ca2+]c


View this table:
[in this window]
[in a new window]
 
Table 15. Intracellular Ca2+ Buffering


View this table:
[in this window]
[in a new window]
 
Table 16. Ca2+ Handling by the Sarcoplasmic Reticulum


View this table:
[in this window]
[in a new window]
 
Table 17. Parameter Values


View this table:
[in this window]
[in a new window]
 
Table 18. Maximum Conductance Values


View this table:
[in this window]
[in a new window]
 
Table 19. Initial Conditions


*    Appendix 1
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
*Appendix 1
down arrowAppendix 2
down arrowReferences
 
Tables 5 through 19UpUpUpUpUpUpUpUpUpUpUpUpUpUpUp contain all the equations, parameter values, and initial conditions necessary to carry out the simulations presented in this article. Unless otherwise noted, the units are as follows: time in seconds (s), voltage in millivolts (mV), concentration in millimoles/liter (mmol/L), current in picoamperes (pA), conductance in nanosiemens (nS), capacitance in nanofarads (nF), volume in nanoliters (nL), and temperature in kelvin (K). The stimulus used to evoke an action potential consists of a rectangular current pulse (Istim) with an amplitude of 280 pA and duration of 6 ms.

All simulations were performed by forward integration of the coupled system of differential equations using the CVODE solver package for ordinary differential equations. (CVODE was developed by S.D. Cohen and A.C. Hindmarsh at Lawrence Livermore National Laboratories, Livermore Calif) Sufficient accuracy was ensured by adjusting the temporal step size of the integration so that the local error in all state variables (as estimated by the CVODE algorithm) satisfied a relative error bound. Computer programs for the simulations were written in the C programming language under the UNIX operating system. Simulations were performed on Sun Microsystems Sparc workstations (Sparc 2, IPX) and on a Micron Millennia Pentium 166 PC running the Linux operating system. At a stimulus frequency of 1 Hz, one cycle (ie, 1 s of data) requires {approx}0.9 s of CPU time on the Pentium 166 platform.


*    Appendix 2
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
up arrowAppendix 1
*Appendix 2
down arrowReferences
 
This Appendix contains a brief derivation of the method used to study the parameter sensitivity of the action potential waveform. The reader is referred to Reference 53 for more detailed information.

Starting from a system of the general form,

we take the partial derivative of Equation 1 with respect to a parameter {alpha}k to obtain the following equation:

The time derivative of the state vector x({alpha}, t) can be written as follows:

where the time derivative of {alpha} vanishes, since all parameters are assumed to be time invariant. Thus, from Equation 1, we have the following:

Interchanging the order of integration, we obtain the following equation:

where {epsilon}k is the sensitivity of the state x to the parameter {alpha}k, ie,

Note, finally, that Equation 5 defines a costate system53 of the same general form as Equation 1, ie,

where

The costate system for each parameter of interest can be integrated along with the original system, yielding the desired sensitivity functions.

Glossary
{tau}Na, {tau}K, {tau}Ca INa

Na+ current

ICa,L

L-type Ca2+ current

It

Transient outward K+ current

Isus

Sustained outward K+ current

IK,s

Slow delayed rectifier K+ current

IK,r

Rapid delayed rectifier K+ current

IK1

Inwardly rectifying K+ current

IB,Na

Background Na+ current

IB,Ca

Background Ca2+ current

INaK

Na+-K+ pump current

ICaP

Sarcolemmal Ca2+ pump current

INaCa

Na+-Ca2+ exchange current

{Phi}Na,en

Electroneutral Na+ influx

Idi

Ca2+ diffusion current from the diffusion-restricted subsarcolemmal space to the cytosol

Iup

Sarcoplasmic reticulum Ca2+ uptake current

Itr

Sarcoplasmic reticulum Ca2+ translocation current (from uptake to release compartment)

Irel

Sarcoplasmic reticulum Ca2+ release current

[Na+]b

Na+ concentration in bulk (bathing) medium

[K+]b

K+ concentration in bulk (bathing) medium

[Ca2+]b

Ca2+ concentration in bulk (bathing) medium

[Na+]c

Na+ concentration in the extracellular cleft space

[K+]c

K+ concentration in the extracellular cleft space

[Ca2+]c

Ca2+ concentration in the extracellular cleft space

[Na+]i

Na+ concentration in the intracellular medium

[K+]i

K+ concentration in the intracellular medium

[Ca2+]i

Ca2+ concentration in the intracellular medium

[Mg2+]i

Mg2+ concentration in the intracellular medium

[Ca2+]d

Ca2+ concentration in the restricted subsarcolemmal space

[Ca2+]up

Ca2+ concentration in the sarcoplasmic reticulum uptake compartment

[Ca2+]rel

Ca2+ concentration in the sarcoplasmic reticulum release compartment

ENa

Equilibrium (Nernst) potential for Na+

EK

Equilibrium (Nernst) potential for K+

ECa

Equilibrium (Nernst) potential for Ca2+

ECa,app

Apparent reversal potential for ICa,L (differs from ECa)

PNa

Permeability for INa

¯gCa,L

Maximum conductance for ICa,L

¯gt

Maximum conductance for It

¯gsus

Maximum conductance for Isus

¯gK,s

Maximum conductance for IK,s

¯gK,r

Maximum conductance for IK,r

¯gK1

Maximum conductance for IK1

¯gB,Na

Maximum conductance for IB,Na

¯gB,Ca

Maximum conductance for IB,Ca

m

Activation gating variable for INa

h1, h2

Fast and slow inactivation gating variables for INa

dL

Activation gating variable for ICa,L

fL1, fL2

Fast and slow inactivation gating variables for ICa,L

fCa

[Ca2+]d-dependent ratio of fast (fL1) to slow (fL2) inactivation of ICa,L

kCa

Half-maximum Ca2+ binding concentration for fCa

r

Activation gating variable for It

s

Inactivation gating variable for It

s1, s2

Rapidly and slowly recovering inactivation gating variables for It

rsus

Activation gating variable for Isus

ssus

Inactivation gating variable for Isus

n

Activation gating variable for IK,s

pa

Activation gating variable for IK,r

pi

Inactivation gating variable (instantaneous) for IK,r

¯m, ¯h1, ...

Steady-state value of m, h1, etc

F1

Relative amount of "inactive precursor" in the Irel formulation

F2

Relative amount of "activator" in the Irel formulation

{tau}m

Activation time constant for INa

{tau}h1, {tau}h2

Fast and slow inactivation time constants for INa

{tau}dL

Activation time constant for ICa,L

{tau}fL1, {tau}fL2

Fast and slow inactivation time constants for ICa,L

{tau}r

Activation time constant for It

{tau}s

Inactivation time constant for It

{tau}s1, {tau}s2

Rapidly and slowly recovering inactivation time constants for It

{tau}rsus

Activation time constant for Isus

{tau}ssus

Inactivation time constant for Isus

{tau}n

Activation time constant for IK,s

{tau}pa

Activation time constant for IK,r

O

Buffer occupancy

OC

Fractional occupancy of the calmodulin buffer by Ca2+

OTC

Fractional occupancy of the troponin-Ca2+ buffer by Ca2+

OTMgC

Fractional occupancy of the troponin-Mg2+ buffer by Ca2+

OTMgMg

Fractional occupancy of the troponin-Mg2+ buffer by Mg2+

OCalse

Fractional occupancy of the calsequestrin buffer (in the sarcoplasmic reticulum release compartment) by Ca2+

R

Universal gas constant

T

Absolute temperature

F

Faraday's constant

Cm

Membrane capacitance

V

Membrane voltage

Volc

Volume of the extracellular cleft space

Voli

Total cytosolic volume

Vold

Volume of the diffusion-restricted subsarcolemmal space

Volup

Volume of the sarcoplasmic reticulum uptake compartment

Volrel

Volume of the sarcoplasmic reticulum release compartment

{tau}Na, {tau}K, {tau}Ca

Time constant of diffusion of Na+, K+, and Ca2+ from the bulk medium to the extracellular cleft space

{tau}di

Time constant of diffusion from the restricted subsarcolemmal space to the cytosol

¯INaK

Maximum Na+-K+ pump current

kNaK,K

Half-maximum K+ binding concentration for INaK

kNaK,Na

Half-maximum Na+ binding concentration for INaK

¯ICaP

Maximum Ca2+ pump current

kCaP

Half-maximum Ca2+ binding concentration for ICaP

kNaCa

Scaling factor for INaCa

{gamma}

Position of energy barrier controlling voltage dependence of INaCa

dNaCa

Denominator constant for INaCa

¯Iup

Maximum sarcoplasmic reticulum uptake current

kcyca

Half-maximum binding concentration for [Ca2+]i to Iup

ksrca

Half-maximum binding concentration for [Ca2+]up to Iup

kxcs

Ratio of forward to back reactions for Iup

{tau}tr

Time constant of diffusion ("translocation") of Ca2+ from sarcoplasmic reticulum uptake to release compartment

{alpha}rel

Scaling factor for Irel

krel,i

Half-activation [Ca2+]i for Irel

krel,d

Half-activation [Ca2+]d for Irel

rrecov

Recovery rate constant for the sarcoplasmic reticulum release channel


*    Acknowledgments
 
Mr Nygren was supported in part by a stipend from a Canadian Medical Research Council group grant. Drs Fiset and Firek are grateful for the support of Alberta Heritage Foundation for Medical Research fellowships. Dr Giles is supported as a medical scientist by the Alberta Heritage Foundation for Medical Research and receives ongoing support from the Canadian Medical Research Council and the Heart and Stroke Foundation of Canada.

Received June 9, 1997; accepted September 30, 1997.


*    References
up arrowTop
up arrowAbstract
up arrowIntroduction
up arrowMaterials and Methods
up arrowResults
up arrowDiscussion
up arrowAppendix 1
up arrowAppendix 2
*References
 
1. Shibata EF, Drury T, Refsum H, Aldrete V, Giles W. Contributions of a transient outward current to repolarization in human atrium. Am J Physiol. 1989;257:H1773–H1781.[Abstract/Free Full Text]

2. Firek L, Giles WR. Outward currents underlying repolarization in human atrial myocytes. Cardiovasc Res. 1995;39:31–38.

3. DiFrancesco D, Noble D. A model of cardiac electrical activity incorporating ionic pumps and concentration changes. Philos Trans R Soc Lond B Biol Sci. 1985;307:353–398.[Abstract/Free Full Text]

4. Hilgemann DW, Noble D. Excitation-contraction coupling and extracellular calcium transients in rabbit atrium: reconstruction of basic cellular mechanisms. Proc R Soc Lond B Biol Sci. 1987;230:163–205.[Medline] [Order article via Infotrieve]

5. Earm YE, Noble D. A model of the single atrial cell: relation between calcium current and calcium release. Proc R Soc Lond B Biol Sci. 1990;240:83–96.[Medline] [Order article via Infotrieve]

6. Rasmusson RL, Clark JW, Giles WR, Robinson K, Clark RB, Shibata EF, Campbell DL. A mathematical model of electrophysiological activity in a bullfrog atrial cell. Am J Physiol. 1990;259:H370–H389.[Abstract/Free Full Text]

7. Rasmusson RL, Clark JW, Giles WR, Shibata EF, Campbell DL. A mathematical model of a bullfrog cardiac pacemaker cell. Am J Physiol. 1990;259:H352–H369.[Abstract/Free Full Text]

8. Luo C-H, Rudy Y. A model of the ventricular cardiac action potential: depolarization, repolarization and their interaction. Circ Res. 1991;68:1501–1526.[Abstract/Free Full Text]

9. Luo C-H, Rudy Y. A dynamic model of the cardiac ventricular action potential, I: simulations of ionic currents and concentration changes. Circ Res. 1994;74:1071–1096.[Abstract/Free Full Text]

10. Luo C-H, Rudy Y. A dynamic model of the cardiac ventricular action potential, II: afterdepolarizations, triggered activity, and potentiation. Circ Res. 1994;74:1097–1113.[Abstract/Free Full Text]

11. Zeng J, Laurita KR, Rosenbaum DS, Rudy Y. Two components of the delayed rectifier K+ current in ventricular myocytes of the guinea pig type: theoretical formulation and their role in repolarization. Circ Res. 1995;77:140–152.[Abstract/Free Full Text]

12. Demir SS, Clark JW, Murphey CR, Giles WR. A mathematical model of a rabbit sinoatrial node cell. Am J Physiol. 1994;266:C832–C852.[Abstract/Free Full Text]

13. Lindblad DS, Murphey CR, Clark JW, Giles WR. A model of the action potential and underlying membrane currents in a rabbit atrial cell. Am J Physiol. 1996;271:H1666–H1691.[Abstract/Free Full Text]

14. Ilnicki T. Electrophysiological and Mechanical Measurements in Human and Rabbit Atria. Calgary, Canada: University of Calgary; 1987. Thesis.

15. Sakakibara Y, Wasserstrom JA, Furukawa T, Jia H, Arentzen CE, Hartz RS, Singer DH. Characterization of the sodium current in single human atrial myocytes. Circ Res. 1992;71:535–546.[Abstract/Free Full Text]

16. Sakakibara Y, Furukawa T, Singer, Donald H, Jia H, Backer CL, Arentzen CE, Wasserstrom JA. Sodium current in isolated human ventricular myocytes. Am J Physiol. 1993;265:H1301–H1309.[Abstract/Free Full Text]

17. Wendt DJ, Starmer F, Grant AO. Na channel kinetics remain stable during perforated-patch recordings. Am J Physiol. 1992;263:C1234–C1240.[Abstract/Free Full Text]

18. Cohen IS, Strichartz GR. On the voltage-dependent action of tetrodotoxin. Biophys J.. 1977;17:275–279.[Medline] [Order article via Infotrieve]

19. Benitah JP, Bailly P, D'Agrosa MC, Da Ponte JP, Delgado C. Slow inward current in single cells isolated from adult human ventricles. Pflugers Arch. 1992;421:176–187.[Medline] [Order article via Infotrieve]

20. Escande D, Coulombe A, Faivre J, Coraboeuf E. Characteristics of the time-dependent slow inward current in adult human atrial single myocytes. J Mol Cell Cardiol. 1986;18:547–551.[Medline] [Order article via Infotrieve]

21. Le Grand B, Hatem S, Deroubaix E, Couétil J-P, Coraboeuf E. Calcium current depression in isolated human atrial myocytes after cessation of chronic treatment with calcium antagonists. Circ Res. 1991;69:292–300.[Abstract/Free Full Text]

22. Le Grand B, Hatem S, Deroubaix E, Couétil J-P, Coraboeuf E. Depressed transient outward and calcium currents in dilated human atria. Cardiovasc Res. 1994;28:548–556.[Medline] [Order article via Infotrieve]

23. Mewes T, Ravens U. L-type calcium currents of human myocytes from ventricle of non-failing and failing hearts and from atrium. J Mol Cell Cardiol. 1994;26:1307–1320.[Medline] [Order article via Infotrieve]

24. Ouadid H, Seguin J, Richard S, Chaptal PA, Nargeot J. Properties and modulation of Ca channels in adult human atrial cells. J Mol Cell Cardiol. 1991;23:41–54.[Medline] [Order article via Infotrieve]

25. Li GR, Nattel S. Properties of human atrial ICa at physiological temperatures and relevance to action potential. Am J Physiol. 1997;272:H227–H235.[Abstract/Free Full Text]

26. Ouadid H, Albat B, Nargeot J. Calcium currents in diseased human cardiac cells. J Cardiovasc Pharmacol. 1995;25:282–291.[Medline] [Order article via Infotrieve]

27. Sun XH, Protasi F, Takahashi M, Takeshima H, Ferguson DG, Franzini-Armstrong C. Molecular architecture of membranes involved in excitation-contraction coupling of cardiac muscle. J Cell Biol. 1995;129:659–671.[Abstract/Free Full Text]

28. Imredy JP, Yue DT. Mechanism of Ca2+-sensitive inactivation of L-type Ca2+ channels. Neuron. 1994;12:1301–1318.[Medline] [Order article via Infotrieve]

29. You Y, Pelzer DJ, Pelzer S. Trypsin and forskolin decrease the sensitivity of L-type calcium current to inhibition by cytoplasmic free calcium in guinea pig heart muscle cells. Biophys J. 1995;69:1838–1846.[Medline] [Order article via Infotrieve]

30. Giles WR, Clark RB, Braun AP. Ca2+-independent transient outward current in mammalian heart. In: Morad M, Ebashi S, Trautwein W, Kurachi Y, eds. Molecular Physiology and Pharmacology of Cardiac Ion Channels and Transporters. Amsterdam, the Netherlands: Kluwer Publishing Ltd; 1996:141–168.

31. Escande D, Coulombe A, Faivre JF, Deroubaix E, Coraboeuf E. Two types of transient outward currents in adult human atrial cells. Am J Physiol. 1987;252:H142–H148.[Abstract/Free Full Text]

32. Gross GJ, Burke RP, Castle NA. Characterization of transient outward current in young human atrial myocytes. Cardiovasc Res. 1995;29:112–117.[Medline] [Order article via Infotrieve]

33. Wettwer E, Amos G, Gath J, Zerkowski HR, Reidemeister JC, Ravens U. Transient outward current in human and rat ventricular myocytes. Cardiovasc Res. 1993;27:1662–1669.[Abstract/Free Full Text]

34. Fedida D, Wible B, Wang Z, Fermini B, Faust F, Nattel S, Brown AM. Identity of a novel delayed rectifier current from human heart with a cloned K+ channel current. Circ Res. 1993;73:210–216.[Abstract]

35. Wang Z, Fermini B, Nattel S. Sustained depolarization-induced outward current in human atrial myocytes: evidence for a novel delayed rectifier K+ current similar to Kv1.5 cloned channel currents. Circ Res. 1993;73:1061–1076.[Abstract/Free Full Text]

36. Näbauer M, Beuckelmann DJ, Erdmann E. Characteristics of transient outward current in human ventricular myocytes from patients with terminal heart failure. Circ Res. 1993;73:386–394.[Abstract/Free Full Text]

37. Agus ZS, Dukes ID, Morad M. Divalent cations modulate the transient outward current in rat ventricular myocytes. Am J Physiol. 1991;261:C310–C318.[Abstract/Free Full Text]

38. Fermini B, Wang Z, Duan D, Nattel S. Differences in rate dependence of transient outward current in rabbit and human atrium. Am J Physiol. 1992;263:H1747–H1754.[Abstract/Free Full Text]

39. Koidl B, Flaschberger P, Schaffer P, Pelzmann B, Bernhart E, Mächler H, Rigler B. Effects of the class III antiarrhythmic drug ambasilide on outward currents in human atrial myocytes. Naunyn Schmiedebergs Arch Pharmacol. 1996;353:226–232.[Medline] [Order article via Infotrieve]

40. Amos GJ, Wettwer E, Metzger F, Li Q, Himmel HM, Ravens U. Differences between outward currents of human atrial and subepicardial ventricular myocytes. J Physiol (Lond). 1996;491:31–50.[Abstract/Free Full Text]

41. Muraki K, Imaizumi Y, Watanabe M, Habuchi Y, Giles WR. Delayed rectifier K+ current in rabbit atrial myocytes. Am J Physiol. 1995;269:H524–H532.[Abstract/Free Full Text]

42. Wang Z, Fermini B, Nattel S. Delayed rectifier outward current and repolarization in human atrial myocytes. Circ Res. 1993;73:276–285.[Abstract/Free Full Text]

43. Liu S, Rasmusson RL, Campbell DL, Wang S, Strauss HC. Activation and inactivation kinetics of an E-4031-sensitive current from single ferret atrial myocytes. Biophys J. 1996;70:2704–2715.[Medline] [Order article via Infotrieve]

44. Wang Z, Fermini B, Nattel S. Rapid and slow components of delayed rectifier current in human atrial myocytes. Cardiovasc Res. 1994;28:1540–1546.[Medline] [Order article via Infotrieve]

45. Sanguinetti MC, Jiang C, Curran ME, Keating MT. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell. 1995;81:299–307.[Medline] [Order article via Infotrieve]

46. Lide DR, ed. CRC Handbook of Chemistry and Physics. Cleveland, Ohio: CRC Press; 1992.

47. Kunze DL. Rate-dependent changes in extracellular potassium in the rabbit atrium. Circ Res. 1977;41:122–127.[Abstract/Free Full Text]

48. Cohen I, Kline R. K+ fluctuations in the extracellular spaces of cardiac muscle: evidence from the voltage-clamp and extracellular K+-selective microelectrodes. Circ Res. 1982;50:1–16.[Free Full Text]

49. Parker I, Zang WJ, Wier WG. Ca2+ sparks involving multiple Ca2+ release sites along Z-lines in rat heart cells. J Physiol (Lond). 1996;497:31–38.[Abstract/Free Full Text]

50. Stern MD. Theory of excitation-contraction coupling in cardiac muscle. Biophys J. 1992;63:497–517.[Medline] [Order article via Infotrieve]

51. Isenberg G, Han S. Gradation of Ca2+-induced Ca2+ release by voltage-clamp pulse duration in potentiated guinea-pig ventricular myocytes. J Physiol (Lond). 1994;480:423–438.[Abstract/Free Full Text]

52. Bénardeau A, Hatem SN, Rucker-Martin C, Le Grand B, Mace L, Dervanian P, Mercadier JJ, Coraboeuf E. Contribution of Na+/Ca2+ exchange to action potential of human atrial myocytes. Am J Physiol. 1996;271:H1151–H1161.[Abstract/Free Full Text]

53. Paulsen RA, Clark JW Jr, Murphy PH, Burdine JA. Sensitivity analysis and improved identification of a systemic arterial model. IEEE Trans Biomed Eng. 1982;29:164–178.[Medline] [Order article via Infotrieve]

54. Le Grand B, Le Heuzey JY, Perier P, Peronneau P, Lavergne T, Hatem S, Guize L. Cellular electrophysiological effects of flecainide on human atrial fibres. Cardiovasc Res.. 1990;24:232–238.[Medline] [Order article via Infotrieve]

55. Wang Z, Pelletier LC, Talajic M, Nattel S. Effects of flecainide and quinidine on human atrial action potentials: role of rate-dependence and comparison with guinea pig, rabbit, and dog tissues. Circulation. 1990;82:274–283.[Abstract/Free Full Text]

56. Wang Z, Fermini B, Nattel S. Effects of flecainide, quinidine, and 4-aminopyridine on transient outward and ultrarapid delayed rectifier currents in human atrial myocytes. J Pharmacol Exp Ther. 1995;272:184–196.[Abstract/Free Full Text]

57. Kottkamp H, Haverkamp W, Borggrefe M, Breithardt G. The role of class III antiarrhythmic drugs in atrial fibrillation. In: Olsson SB, Allessie MA, Campbell RWF, eds. Atrial Fibrillation: Mechanisms and Therapeutic Strategies. Armonk, NY: Futura Publishing Co Inc; 1994:287–306.

58. Li G-R, Feng J, Wang Z, Fermini B, Nattel S. Adrenergic modulation of ultrarapid delayed rectifier K+ current in human atrial myocytes. Circ Res. 1995;78:903–915.[Abstract/Free Full Text]

59. Van Wagoner DR, Pond AL, McCarthy PM, Trimmer JS, Nerbonne JM. Outward K+ current densities and Kv1.5 expression are reduced in chronic human atrial fibrillation. Circ Res. 1997;80:772–781.[Abstract/Free Full Text]

60. Yue L, Feng J, Li GR, Nattel S. Transient outward and delayed rectifier currents in canine atrium: properties and role of isolation methods. Am J Physiol. 1996;270:H2157–H2168.[Abstract/Free Full Text]

61. Clark RB, Sanchez-Chapula J, Salinas-Stefanon E, Duff HJ, Giles WR. Quinidine-induced open channel block of K+ current in rat ventricle. Br J Pharmacol. 1995;115:335–343.[Medline] [Order article via Infotrieve]

62. Hatem SN, Bénardeau A, Rücker-Martin C, Marty I, de Chamisso P, Villaz M, Mercadier J-J. Different compartments of sarcoplasmic reticulum participate in the excitation-contraction coupling process in human atrial myocytes. Circ Res. 1997;80:345–353.[Abstract/Free Full Text]




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. M. Maleckar, J. L. Greenstein, W. R. Giles, and N. A. Trayanova
K+ current changes account for the rate dependence of the action potential in the human atrial myocyte
Am J Physiol Heart Circ Physiol, October 1, 2009; 297(4): H1398 - H1410.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
F. H. Fenton, S. Luther, E. M. Cherry, N. F. Otani, V. Krinsky, A. Pumir, E. Bodenschatz, and R. F. Gilmour Jr
Termination of Atrial Fibrillation Using Pulsed Low-Energy Far-Field Stimulation
Circulation, August 11, 2009; 120(6): 467 - 476.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc AHome page
S. Severi, C. Corsi, and E. Cerbai
From in vivo plasma composition to in vitro cardiac electrophysiology and in silico virtual heart: the extracellular calcium enigma
Phil Trans R Soc A, June 13, 2009; 367(1896): 2203 - 2223.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc AHome page
P. Stewart, O. V. Aslanidi, D. Noble, P. J. Noble, M. R. Boyett, and H. Zhang
Mathematical models of the electrical action potential of Purkinje fibre cells
Phil Trans R Soc A, June 13, 2009; 367(1896): 2225 - 2255.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc AHome page
S. Linge, J. Sundnes, M. Hanslien, G.T. Lines, and A. Tveito
Numerical solution of the bidomain equations
Phil Trans R Soc A, May 28, 2009; 367(1895): 1931 - 1950.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
S. Nattel
Delayed-rectifier potassium currents and the control of cardiac repolarization: Noble and Tsien 40 years after
J. Physiol., December 15, 2008; 586(24): 5849 - 5852.
[Full Text] [PDF]


Home page
Phil Trans R Soc AHome page
A. Garny, D. P Nickerson, J. Cooper, R. W. d. Santos, A. K Miller, S. McKeever, P. M.F Nielsen, and P. J Hunter
CellML and associated tools and techniques
Phil Trans R Soc A, September 13, 2008; 366(1878): 3017 - 3043.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
M. E. Mangoni and J. Nargeot
Genesis and Regulation of the Heart Automaticity
Physiol Rev, July 1, 2008; 88(3): 919 - 982.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. K. Landeen, D. A. Dederko, C. S. Kondo, B. S. Hu, N. Aroonsakool, J. H. Haga, and W. R. Giles
Mechanisms of the negative inotropic effects of sphingosine-1-phosphate on adult mouse ventricular myocytes
Am J Physiol Heart Circ Physiol, February 1, 2008; 294(2): H736 - H749.
[Abstract] [Full Text] [PDF]


Home page
J. Neurophysiol.Home page
A. V. Olypher and R. L. Calabrese
Using Constraints on Neuronal Activity to Reveal Compensatory Changes in Neuronal Parameters
J Neurophysiol, December 1, 2007; 98(6): 3749 - 3758.
[Abstract] [Full Text] [PDF]


Home page
J Biol RhythmsHome page
Choon Kiat Sim and D. B. Forger
Modeling the Electrophysiology of Suprachiasmatic Nucleus Neurons
J Biol Rhythms, October 1, 2007; 22(5): 445 - 453.
[Abstract] [PDF]


Home page
CirculationHome page
B. London, C. Albert, M. E. Anderson, W. R. Giles, D. R. Van Wagoner, E. Balk, G. E. Billman, M. Chung, W. Lands, A. Leaf, et al.
Omega-3 Fatty Acids and Cardiac Arrhythmias: Prior Studies and Recommendations for Future Research: A Report from the National Heart, Lung, and Blood Institute and Office of Dietary Supplements Omega-3 Fatty Acids and Their Role in Cardiac Arrhythmogenesis Workshop
Circulation, September 4, 2007; 116(10): e320 - e335.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
K. Tsujimae, S. Suzuki, S. Murakami, and Y. Kurachi
Frequency-dependent effects of various IKr blockers on cardiac action potential duration in a human atrial model
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H660 - H669.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. C. B. Jacobsen, C. Aalkjaer, H. Nilsson, V. V. Matchkov, J. Freiberg, and N.-H. Holstein-Rathlou
Activation of a cGMP-sensitive calcium-dependent chloride channel may cause transition from calcium waves to whole cell oscillations in smooth muscle cells
Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H215 - H228.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y.-J. Qu, V. E. Bondarenko, C. Xie, S. Wang, M. S. Awayda, H. C. Strauss, and M. J. Morales
W-7 modulates Kv4.3: pore block and Ca2+-calmodulin inhibition
Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2364 - H2377.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
D. Noble
From the Hodgkin-Huxley axon to the virtual heart
J. Physiol., April 1, 2007; 580(1): 15 - 22.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
R. Otway, J. I. Vandenberg, G. Guo, A. Varghese, M. L. Castro, J. Liu, J. Zhao, J. A. Bursill, K. R. Wyse, H. Crotty, et al.
Stretch-Sensitive KCNQ1 Mutation: A Link Between Genetic and Environmental Factors in the Pathogenesis of Atrial Fibrillation?
J. Am. Coll. Cardiol., February 6, 2007; 49(5): 578 - 586.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
E. M. Cherry and F. H. Fenton
A tale of two dogs: analyzing two models of canine ventricular electrophysiology
Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H43 - H55.
[Abstract] [Full Text] [PDF]


Home page
Phil Trans R Soc AHome page
M. Fink, W. R Giles, and D. Noble
Contributions of inwardly rectifying K+ currents to repolarization assessed using mathematical models of human ventricular myocytes
Phil Trans R Soc A, May 15, 2006; 364(1842): 1207 - 1222.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. E. Pollard and R. C. Barr
Cardiac microimpedance measurement in two-dimensional models using multisite interstitial stimulation
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1976 - H1987.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
R. Ochi, Y. Momose, K. Oyama, and W. R. Giles
Sphingosine-1-phosphate effects on guinea pig atrial myocytes: Alterations in action potentials and K+ currents
Cardiovasc Res, April 1, 2006; 70(1): 88 - 96.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Qu
Critical mass hypothesis revisited: role of dynamical wave stability in spontaneous termination of cardiac fibrillation
Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H255 - H263.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Z. Qu and J. N. Weiss
Effects of Na+ and K+ channel blockade on vulnerability to and termination of fibrillation in simulated normal cardiac tissue
Am J Physiol Heart Circ Physiol, October 1, 2005; 289(4): H1692 - H1701.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
T. Krogh-Madsen, P. Schaffer, A. D. Skriver, L. K. Taylor, B. Pelzmann, B. Koidl, and M. R. Guevara
An ionic model for rhythmic activity in small clusters of embryonic chick ventricular cells
Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H398 - H413.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. Zhang, C. J. Garratt, J. Zhu, and A. V. Holden
Role of up-regulation of IK1 in action potential shortening associated with atrial fibrillation in humans
Cardiovasc Res, June 1, 2005; 66(3): 493 - 502.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
C. Terrenoire, C. E. Clancy, J. W. Cormier, K. J. Sampson, and R. S. Kass
Autonomic Control of Cardiac Action Potentials: Role of Potassium Channel Kinetics in Response to Sympathetic Stimulation
Circ. Res., March 18, 2005; 96(5): e25 - e34.
[Abstract] [Full Text] [PDF]


Home page
EuropaceHome page
A. M. Goodman, R. A. Oliver, C. S. Henriquez, and P. D. Wolf
A membrane model of electrically remodelled atrial myocardium derived from in vivo measurements
Europace, January 1, 2005; 7(s2): S135 - S145.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. L. Winslow and J. L. Greenstein
The Ongoing Journey to Understand Heart Function Through Integrative Modeling
Circ. Res., December 10, 2004; 95(12): 1135 - 1136.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Zorn-Pauly, P. Schaffer, B. Pelzmann, P. Lang, H. Machler, B. Rigler, and B. Koidl
If in left human atrium: a potential contributor to atrial ectopy
Cardiovasc Res, November 1, 2004; 64(2): 250 - 259.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
E. Wettwer, O. Hala, T. Christ, J. F. Heubach, D. Dobrev, M. Knaut, A. Varro, and U. Ravens
Role of IKur in Controlling Action Potential Shape and Contractility in the Human Atrium: Influence of Chronic Atrial Fibrillation
Circulation, October 19, 2004; 110(16): 2299 - 2306.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
V. Trepanier-Boulay, M.-A. Lupien, C. St-Michel, and C. Fiset
Postnatal development of atrial repolarization in the mouse
Cardiovasc Res, October 1, 2004; 64(1): 84 - 93.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
V. E. Bondarenko, G. P. Szigeti, G. C. L. Bett, S.-J. Kim, and R. L. Rasmusson
Computer model of action potential of mouse ventricular myocytes
Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1378 - H1403.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
D. Noble
Modeling the Heart
Physiology, August 1, 2004; 19(4): 191 - 197.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Wang, H. Wang, Y. Zhang, H. Gao, S. Nattel, and Z. Wang
Impairment of HERG K+ Channel Function by Tumor Necrosis Factor-{alpha}: ROLE OF REACTIVE OXYGEN SPECIES AS A MEDIATOR
J. Biol. Chem., April 2, 2004; 279(14): 13289 - 13292.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
A. G. KLEBER and Y. RUDY
Basic Mechanisms of Cardiac Impulse Propagation and Associated Arrhythmias
Physiol Rev, April 1, 2004; 84(2): 431 - 488.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. E. Lomax, C. S. Kondo, and W. R. Giles
Comparison of time- and voltage-dependent K+ currents in myocytes from left and right atria of adult mice
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1837 - H1848.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
L. E. Fridlyand, N. Tamarina, and L. H. Philipson
Modeling of Ca2+ flux in pancreatic {beta}-cells: role of the plasma membrane and intracellular stores
Am J Physiol Endocrinol Metab, July 1, 2003; 285(1): E138 - E154.
[Abstract] [Full Text] [PDF]


Home page
J. Physiol.Home page
J. Brouillette, V. Trepanier-Boulay, and C. Fiset
Effect of androgen deficiency on mouse ventricular repolarization
J. Physiol., January 15, 2003; 546(2): 403 - 413.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Kurata, I. Hisatome, S. Imanishi, and T. Shibamoto
Dynamical description of sinoatrial node pacemaking: improved mathematical model for primary pacemaker cell
Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H2074 - H2101.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
F. Xie, Z. Qu, A. Garfinkel, and J. N. Weiss
Electrical refractory period restitution and spiral wave reentry in simulated cardiac tissue
Am J Physiol Heart Circ Physiol, July 1, 2002; 283(1): H448 - H460.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
O. Bernus, R. Wilders, C. W. Zemlin, H. Verschelde, and A. V. Panfilov
A computationally efficient electrophysiological model of human ventricular cells
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2296 - H2308.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. Kneller, R. Zou, E. J. Vigmond, Z. Wang, L. J. Leon, and S. Nattel
Cholinergic Atrial Fibrillation in a Computer Model of a Two-Dimensional Sheet of Canine Atrial Cells With Realistic Ionic Properties
Circ. Res., May 17, 2002; 90 (9): e73 - e87.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Members of the Sicilian Gambit
New Approaches to Antiarrhythmic Therapy, Part I: Emerging Therapeutic Applications of the Cell Biology of Cardiac Arrhythmias
Circulation, December 4, 2001; 104(23): 2865 - 2873.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
Members of the Sicilian Gambit
New approaches to antiarrhythmic therapy; emerging therapeutic applications of the cell biology of cardiac arrhythmias
Eur. Heart J., December 1, 2001; 22(23): 2148 - 2163.
[Abstract] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
J. L. Puglisi and D. M. Bers
LabHEART: an interactive computer model of rabbit ventricular myocyte ion channels and Ca transport
Am J Physiol Cell Physiol, December 1, 2001; 281(6): C2049 - C2060.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
Members of the Sicilian Gambit
New approaches to antiarrhythmic therapy: emerging therapeutic applications of the cell biology of cardiac arrhythmias
Cardiovasc Res, December 1, 2001; 52(3): 345 - 360.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Restivo, D. O. Kozhevnikov, and M. Boutjdir
Optical mapping of activation patterns in an animal model of congenital heart block
Am J Physiol Heart Circ Physiol, April 1, 2001; 280(4): H1889 - H1895.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
R. J. Ramirez, S. Nattel, and M. Courtemanche
Mathematical analysis of canine atrial action potentials: rate, regional factors, and electrical remodeling
Am J Physiol Heart Circ Physiol, October 1, 2000; 279(4): H1767 - H1785.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
David M. Harrild, Craig S. Henriquez ;
A Computer Model of Normal Conduction in the Human Atria
Circ. Res., September 29, 2000; 87 (7): e25 - e36.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. S. Spach, J. F. Heidlage, P. C. Dolber, and R. C. Barr
Electrophysiological Effects of Remodeling Cardiac Gap Junctions and Cell Size : Experimental and Model Studies of Normal Cardiac Growth
Circ. Res., February 18, 2000; 86(3): 302 - 311.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Courtemanche, R. J Ramirez, and S. Nattel
Ionic targets for drug therapy and atrial fibrillation-induced electrical remodeling: insights from a mathematical model
Cardiovasc Res, May 1, 1999; 42(2): 477 - 489.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
L. Priebe and D. J. Beuckelmann
Simulation Study of Cellular Electric Properties in Heart Failure
Circ. Res., June 15, 1998; 82(11): 1206 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
J. Kneller, R. J. Ramirez, D. Chartier, M. Courtemanche, and S. Nattel
Time-dependent transients in an ionically based mathematical model of the canine atrial action potential
Am J Physiol Heart Circ Physiol, April 1, 2002; 282(4): H1437 - H1451.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
O. Bernus, R. Wilders, C. W. Zemlin, H. Verschelde, and A. V. Panfilov
A computationally efficient electrophysiological model of human ventricular cells
Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2296 - H2308.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nygren, A.
Right arrow Articles by Giles, W. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nygren, A.
Right arrow Articles by Giles, W. R.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*CALCIUM COMPOUNDS
*CALCIUM, ELEMENTAL
*POTASSIUM